VIR BIOTECHNOLOGY INC (VIR) Top Institutional Shareholders

VIR BIOTECHNOLOGY INC (VIR) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.23B in VIR holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of VIR tracked by InsiderSet, reporting ownership valued at approximately $161.27M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $167.38M, representing an estimated gain of +3.79% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 59% of the total disclosed VIR value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Arch Venture Management, Llc, Sb Investment Advisers (Uk) Ltd, and several other long-term asset managers with concentrated positions in VIR BIOTECHNOLOGY INC (VIR).

This page ranks the largest institutional VIR shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

247

Total Reported Value

$1.23B

Largest Holder

Blackrock, Inc.

Largest Position

$161.27M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

140

Funds Exiting Positions

0

Page 1 of 5
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%17,998,329$161,265,028$167,384,460+$6,119,432+3.79%
Arch Venture Management, Llc17.09%12,916,663$115,733,300$120,124,966+$4,391,666+3.79%
Sb Investment Advisers (Uk) Ltd1.27%10,948,093$98,094,913$101,817,265+$3,722,352+3.79%
Vanguard Portfolio Management Llc0.00%9,215,577$82,571,570$85,704,866+$3,133,296+3.79%
Gsk Plc12.79%8,550,954$76,616,548$79,523,872+$2,907,324+3.79%
State Street Corp0.00%7,141,094$63,984,202$66,412,174+$2,427,972+3.79%
Vanguard Capital Management Llc0.00%5,382,103$48,223,643$50,053,558+$1,829,915+3.79%
Goldman Sachs Group Inc0.00%3,250,227$29,122,034$30,227,111+$1,105,077+3.79%
Morgan Stanley0.00%2,854,205$25,573,682$26,544,107+$970,425+3.79%
Adar1 Capital Management, Llc1.48%2,744,714$24,592,637$25,525,840+$933,203+3.79%
Geode Capital Management, Llc0.00%2,657,843$23,819,795$24,717,940+$898,145+3.77%
Dimensional Fund Advisors Lp0.00%2,579,678$23,107,432$23,991,005+$883,573+3.82%
Citadel Advisors Llc0.01%2,098,476$18,802,345$19,515,827+$713,482+3.79%
Fmr Llc0.00%2,071,848$18,563,762$19,268,186+$704,424+3.79%
Soleus Capital Management, L.P.0.73%2,002,000$17,937,920$18,618,600+$680,680+3.79%
Point72 Asset Management, L.P.0.03%1,952,234$17,492,017$18,155,776+$663,759+3.79%
Boxer Capital Management, Llc2.20%1,866,000$16,719,360$17,353,800+$634,440+3.79%
Gordonmd Global Investments Lp9.48%1,518,552$13,606,226$14,122,534+$516,308+3.79%
Sio Capital Management, Llc1.94%1,498,620$13,427,635$13,937,166+$509,531+3.79%
Pictet Asset Management Holding Sa0.01%1,480,828$13,268,219$13,771,700+$503,481+3.79%
Hudson Bay Capital Management Lp0.08%1,469,510$13,166,810$13,666,443+$499,633+3.79%
Jacobs Levy Equity Management, Inc0.05%1,442,336$12,923,331$13,413,725+$490,394+3.79%
Two Sigma Investments, Lp0.01%1,439,494$12,897,866$13,387,294+$489,428+3.79%
Qube Research & Technologies Ltd0.02%1,248,669$11,188,074$11,612,622+$424,548+3.79%
Clearstead Advisors, Llc0.10%1,216,400$10,898,944$11,312,520+$413,576+3.79%
Jones Hill Capital Lp2.30%1,198,213$10,735,988$11,143,381+$407,393+3.79%
Charles Schwab Investment Management Inc0.00%1,171,684$10,498,289$10,896,661+$398,372+3.79%
Candriam S.C.A.0.05%1,135,763$10,176,436$10,562,596+$386,160+3.79%
Bnp Paribas Financial Markets0.01%1,078,020$9,659,059$10,025,586+$366,527+3.79%
Ensign Peak Advisors, Inc0.02%1,070,812$9,594,476$9,958,552+$364,076+3.79%
Nuveen, Llc0.00%1,018,964$9,129,918$9,476,365+$346,447+3.79%
Northern Trust Corp0.00%985,435$8,829,496$9,164,546+$335,050+3.79%
Bank Of America Corp0.00%965,814$8,653,694$8,982,070+$328,376+3.79%
D. E. Shaw & Co., Inc.0.01%817,685$7,326,458$7,604,471+$278,013+3.79%
Renaissance Technologies LLCJim Simons0.01%761,364$6,821,821$7,080,685+$258,864+3.79%
Ubs Group Ag0.00%744,142$6,667,512$6,920,521+$253,009+3.79%
Vanguard Fiduciary Trust Co0.00%731,721$6,556,220$6,805,005+$248,785+3.79%
Superstring Capital Management Lp4.68%730,548$6,545,710$6,794,096+$248,386+3.79%
Avidity Partners Management Lp1.43%619,300$6,326,150$5,759,490-$566,660-8.96%
Walleye Capital Llc0.04%665,584$5,963,633$6,189,931+$226,298+3.79%
Bank Of New York Mellon Corp0.00%584,047$5,233,058$5,431,637+$198,579+3.79%
Nordea Investment Management Ab0.00%580,755$5,093,221$5,401,022+$307,801+6.04%
Aqr Capital Management Llc0.00%566,009$5,071,437$5,263,884+$192,447+3.79%
Principal Financial Group Inc0.00%547,753$4,907,867$5,094,103+$186,236+3.79%
Empyrean Capital Partners, Lp0.16%527,800$4,729,088$4,908,540+$179,452+3.79%
Alta Partners Management Company, L.P.3.03%509,917$4,568,856$4,742,228+$173,372+3.79%
Parkman Healthcare Partners Llc0.46%500,000$4,480,000$4,650,000+$170,000+3.79%
Millennium Management Llc0.00%489,360$4,384,666$4,551,048+$166,382+3.79%
Invesco Ltd.0.00%421,332$3,775,135$3,918,388+$143,253+3.79%
Public Sector Pension Investment Board0.01%403,795$3,618,003$3,755,294+$137,291+3.79%

Frequently asked questions about VIR

  • Who owns the most VIR stock?

    The largest holders of VIR are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for VIR BIOTECHNOLOGY INC (VIR).

  • Is VIR widely held by superinvestors?

    Many widely followed stocks like VIR appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly VIR is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.